Predictors of long-term survival after resection of adenocarcinoma arising from intraductal papillary mucinous neoplasm and derivation of a prognostic model: An international multicenter study (ADENO-IPMN study)

被引:1
作者
Lucocq, James [1 ]
Joseph, Nejo [2 ]
Hawkyard, Jake [2 ]
Haugk, Beate [2 ]
White, Steve [2 ]
Lye, Jonathan [2 ]
Parkinson, Daniel [2 ]
Mownah, Omar [3 ]
Menon, Krishna [3 ]
Furukawa, Takaki [4 ]
Hirose, Yuki [4 ]
Sasahira, Naoki [4 ]
Inoue, Yosuke [4 ]
Mittal, Anubhav [5 ]
Samra, Jas [5 ]
Sheen, Amy [6 ]
Feretis, Michael [7 ]
Balakrishnan, Anita [7 ]
Ceresa, Carlo [8 ]
Davidson, Brian [8 ]
Pande, Rupaly [9 ]
Dasari, Bobby [9 ]
Roberts, Keith [9 ]
Tanno, Lulu [10 ]
Karavias, Dimitrios [10 ]
Helliwell, Jack [11 ]
Young, Alistair [11 ]
Marks, Kate [11 ]
Nunes, Quentin [12 ]
Urbonas, Tomas [13 ]
Silva, Michael [13 ]
Gordon-Weeks, Alex [13 ]
Barrie, Jenifer [14 ]
Gomez, Dhanny [14 ]
van Laarhoven, Stijn [15 ]
Nawara, Hossam [15 ]
Doyle, Joseph [16 ]
Bhogal, Ricky [16 ]
Harrison, Ewen [17 ]
Roalso, Marcus [18 ]
Ciprani, Debora [19 ]
Aroori, Somaiah [19 ]
Ratnayake, Bathiya [20 ]
Koea, Jonathan [20 ]
Capurso, Gabriele [21 ,22 ]
Stattner, Stefan [23 ]
Bellotti, Ruben [24 ]
Alsaoudi, Tareq [24 ]
Bhardwaj, Neil [24 ]
Rajesh, Srujan [24 ]
机构
[1] NHS Lothian, Dept Gen Surg, Aberdeen, Scotland
[2] Freeman Rd Hosp, Hepatopancreatobiliary & Transplant Unit, Newcastle Upon Tyne, England
[3] Kings Coll Hosp London, Dept Hepatobiliary & Pancreat Surg, Denmark Hill, London, England
[4] Canc Inst Hosp Japanese Fdn Canc Res, Hepatobiliary Pancreat Med Dept, Tokyo, Japan
[5] Royal North Shore Hosp, Sydney, NSW, Australia
[6] Royal North Shore Hosp, Dept Anat Pathol, New South Wales Hlth Pathol, Sydney, NSW, Australia
[7] Addenbrookes Hosp, Cambridge Hepatobiliary & Pancreat Surg Unit, Cambridge, England
[8] Royal Free Hosp, Hepatobiliary & Pancreat Surg Unit, London, England
[9] Queen Elizabeth Hosp Birmingham, Univ Hosp Birmingham NHS Fdn Trust, Hepatobiliary & Pancreat Surg Unit, Birmingham, England
[10] Univ Hosp Southampton, Hepatobiliary & Pancreat Surg Unit, Acad Surg Unit, Southampton, England
[11] Leeds Teaching Hosp NHS Fdn Trust, Hepatobiliary & Pancreat Surg Unit, Leeds, England
[12] East Lancashire Teaching Hosp NHS Trust, Dept Hepatobiliary Surg, Blackburn, Lancs, England
[13] Oxford Univ Hosp NHS Fdn Trust, Oxford Hepatopancreatobiliary HPB Surg Unit, Oxford, England
[14] Nottingham Univ Hosp NHS Fdn Trust, Nottingham Hepatopancreaticoniliary HPB Serv, Nottingham, England
[15] Univ Hosp Bristol & Weston NHS Fdn trust, Dept Hepatobiliary & Pancreat Surg, Bristol, England
[16] Royal Marsden NHS Fdn Trust, Gastrointestinal Unit, London, England
[17] Univ Edinburgh, Dept Clin Surg, Edinburgh, Scotland
[18] Stavanger Univ Hosp, Dept Gastrointestinal Surg, Stavanger, Norway
[19] Univ Hosp Plymouth NHS Trust, Hepatopancreatobiliary Unit, Plymouth, England
[20] North Shore Hosp, Hepatopancreaticobiliary Upper Gastrointestinal Un, Auckland, New Zealand
[21] S Andrea Hosp, Digest & Dis Unit, Rome, Italy
[22] Univ Vita Salute San Raffaele, San Raffaele Sci Inst IRCCS, Pancreas Ctr, Milan, Italy
[23] Med Univ Innsbruck, Dept Visceral Transplant & Thorac Surg, Innsbruck, Austria
[24] Univ Hosp Leicester NHS Trust, Leicester Hepatopancreatobiliary Unit, Leicester, England
[25] Christchurch Hosp, Dept Gen & Vasc Surg, Canterbury Dist Hlth Board, Canterbury, New Zealand
[26] Univ Glasgow, Res Inst Canc Sci, Wolfson Wohl Canc Res Ctr, Glasgow, Scotland
[27] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
关键词
PANCREATIC-CANCER; ADJUVANT THERAPY; MANAGEMENT; DISTINCT; IMPACT;
D O I
10.1016/j.surg.2024.05.010
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Predictors of long-term survival after resection of adenocarcinoma arising from intraductal papillary mucinous neoplasms are unknown. This study determines predictors of long-term (>5 years) disease-free survival and recurrence in adenocarcinoma arising from intraductal papillary mucinous neoplasms and derives a prognostic model for disease-free survival. Methods: Consecutive patients who underwent pancreatic resection for adenocarcinoma arising from intraductal papillary mucinous neoplasms in 18 academic pancreatic centers in Europe and Asia between 2010 to 2017 with at least 5-year follow-up were identified. Factors associated with disease-free survival were determined using Cox proportional hazards model. Internal validation was performed, and discrimination and calibration indices were assessed. Results: In the study, 288 patients (median age, 70 years; 52% male) were identified; 140 (48%) patients developed recurrence after a median follow-up of 98 months (interquartile range, 78.4-123), 57 patients (19.8%) developed locoregional recurrence, and 109 patients (37.8%) systemic recurrence. At 5 years after resection, the overall and disease-free survival was 46.5% (134/288) and 35.0% (101/288), respectively. On Cox proportional hazards model analysis, multivisceral resection (hazard ratio, 2.20; 95% confidence interval, 1.06-4.60), pancreatic tail location (hazard ratio, 2.34; 95% confidence interval, 1.22-4.50), poor tumor differentiation (hazard ratio, 2.48; 95% confidence interval, 1.10-5.30), lymphovascular invasion (hazard ratio, 1.74; 95% confidence interval, 1.06-2.88), and perineural invasion (hazard ratio, 1.83; 95% confidence interval, 1.09-3.10) were negatively associated with long-term disease-free survival. The final predictive model incorporated 8 predictors and demonstrated good predictive ability for disease-free survival (C-index, 0.74; calibration, slope 1.00). Conclusion: A third of patients achieve long-term disease-free survival (>5 years) after pancreatic resection for adenocarcinoma arising from intraductal papillary mucinous neoplasms. The predictive model developed in the current study can be used to estimate the probability of long-term disease-free survival. (c) 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:890 / 898
页数:9
相关论文
共 28 条
[1]   Intraductal Papillary Mucinous Neoplasms of The Pancreas: A Nationwide Registry-Based Study [J].
Aronsson, L. ;
Andersson, B. ;
Andersson, R. ;
Tingstedt, B. ;
Bratlie, S. O. ;
Ansari, D. .
SCANDINAVIAN JOURNAL OF SURGERY, 2018, 107 (04) :302-307
[2]   Preferential Expression of MUC6 in Oncocytic and Pancreatobiliary Types of Intraductal Papillary Neoplasms Highlights a Pyloropancreatic Pathway, Distinct From the Intestinal Pathway, in Pancreatic Carcinogenesis [J].
Basturk, Olca ;
Khayyata, Said ;
Klimstra, David S. ;
Hruban, Ralph H. ;
Zamboni, Giuseppe ;
Coban, Ipek ;
Adsay, Nazmi Volkan .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2010, 34 (03) :364-370
[3]  
Cameron JL, 2006, ANN SURG, V244, P10, DOI 10.1097/01.sla.0000217673.04165.ea
[4]   Adjuvant Chemotherapy in the Treatment of Intraductal Papillary Mucinous Neoplasms of the Pancreas: Systematic Review and Meta-Analysis [J].
Chong, Eric ;
Ratnayake, Bathiya ;
Dasari, Bobby V. M. ;
Loveday, Benjamin P. T. ;
Siriwardena, Ajith K. ;
Pandanaboyana, Sanjay .
WORLD JOURNAL OF SURGERY, 2022, 46 (01) :223-234
[5]   The STROBE guidelines [J].
Cuschieri, Sarah .
SAUDI JOURNAL OF ANAESTHESIA, 2019, 13 :31-34
[6]   European evidence-based guidelines on pancreatic cystic neoplasms [J].
Del Chiaro, Marco ;
Besselink, Marc G. ;
Scholten, Lianne ;
Bruno, Marco J. ;
Cahen, Djuna L. ;
Gress, Thomas M. ;
van Hooft, Jeanin E. ;
Lerch, Markus M. ;
Mayerle, Julia ;
Hackert, Thilo ;
Satoi, Sohei ;
Zerbi, Alessandro ;
Cunningham, David ;
De Angelis, Claudio ;
Giovanni, Marc ;
de-Madaria, Enrique ;
Hegyi, Peter ;
Rosendahl, Jonas ;
Friess, Helmut ;
Manfredi, Riccardo ;
Levy, Philippe ;
Real, Francisco X. ;
Sauvanet, Alain ;
Abu Hilal, Mohammed ;
Marchegiani, Giovanni ;
Esposito, Irene ;
Ghaneh, Paula ;
Engelbrecht, Marc R. W. ;
Fockens, Paul ;
van Huijgevoort, Nadine C. M. ;
Wolfgang, Christopher ;
Bassi, Claudio ;
Gubergrits, Natalya B. ;
Verbeke, Caroline ;
Kloppel, Gunter ;
Scarpa, Aldo ;
Zamboni, Giuseppe ;
Lennon, Anne Marie ;
Sund, Malin ;
Kartalis, Nikolaos ;
Grenacher, Lars ;
Falconi, Massimo ;
Arnelo, Urban ;
Kopchak, Kostantin V. ;
Oppong, Kofi ;
McKay, Colin ;
Hauge, Truls ;
Conlon, Kevin ;
Adham, Mustapha ;
Ceyhan, Guralp O. .
GUT, 2018, 67 (05) :789-804
[7]   What is the Incidence of Malignancy in Resected Intraductal Papillary Mucinous Neoplasms? An Analysis of Over 100 US Institutions in a Single Year [J].
El Khoury, Rym ;
Kabir, Christopher ;
Maker, Vijay K. ;
Banulescu, Mihaela ;
Wasserman, Margaret ;
Maker, Ajay V. .
ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (06) :1746-1751
[8]  
Fernandez-Cruz Laureano, 2005, HPB (Oxford), V7, P93, DOI 10.1080/13651820510028972
[9]   The Declaration of Helsinki [J].
Goodyear, Michael D. E. ;
Krleza-Jeric, Karmela ;
Lernmens, Trudo .
BRITISH MEDICAL JOURNAL, 2007, 335 (7621) :624-625
[10]   Predictors, Patterns, and Timing of Recurrence Provide Insight into the Disease Biology of Invasive Carcinomas Arising in Association with Intraductal Papillary Mucinous Neoplasms [J].
Habib, Joseph R. ;
Kinny-Koster, Benedict ;
Amini, Neda ;
Shoucair, Sami ;
Cameron, John L. ;
Thompson, Elizabeth D. ;
Fishman, Elliot K. ;
Hruban, Ralph H. ;
Javed, Ammar A. ;
He, Jin ;
Wolfgang, Christopher L. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2022, 26 (11) :2311-2320